Sort by
Refine Your Search
-
focus will be on developing compact, efficient, and real-time LLM algorithms/hardware on the edge and developing demos for specific applications such as speech disorder therapy. Your responsibilities will
-
limitations. The field of interpretable machine learning aims to fill this gap by developing interpretable models and algorithms for learning from data. Meanwhile, the field of knowledge discovery and data
-
, the researcher will develop theory and algorithms for (hybrid) model selection that allows to exploit domain knowledge through interactive learning. For this we will build on the minimum description length (MDL
-
optimisation algorithms to optimize the designs. We now hire three PhD candidates who be based at LIACS (Leiden University) and spend several months with industry and academic partners abroad. The GenAIDE
-
optimisation algorithms to optimize the designs. We now hire three PhD candidates who be based at LIACS (Leiden University) and spend several months with industry and academic partners abroad. The GenAIDE
-
of topics include algorithmic fairness in network analysis, developing network embedding frameworks for real-world network datasets or AI models based on agentic LLMs for simulating real-world network data
-
role in the Netherlands. However, given its environmental impact, the sector must be decarbonised in line with Dutch climate targets. Achieving this requires the development of innovative, transformative
-
economic role in the Netherlands. However, given its environmental impact, the sector must be decarbonised in line with Dutch climate targets. Achieving this requires the development of innovative
-
interdisciplinary team and explore the complex relationship between behavior and brain health. This project focuses on developing novel measures of brain health by analyzing everyday behavioral patterns. What you
-
, synthetic chemists team up with immunologists from the Leiden University Medical Centre and computational scientists from the TU Delft to develop the next generation of synthetic CAAR cell therapy for serious